ES315612A1 - Procedimiento para la preparacion de una composicion anticoccidial. - Google Patents

Procedimiento para la preparacion de una composicion anticoccidial.

Info

Publication number
ES315612A1
ES315612A1 ES0315612A ES315612A ES315612A1 ES 315612 A1 ES315612 A1 ES 315612A1 ES 0315612 A ES0315612 A ES 0315612A ES 315612 A ES315612 A ES 315612A ES 315612 A1 ES315612 A1 ES 315612A1
Authority
ES
Spain
Prior art keywords
translation
preparation
machine
legally binding
google translate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0315612A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of ES315612A1 publication Critical patent/ES315612A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES0315612A 1964-07-20 1965-07-20 Procedimiento para la preparacion de una composicion anticoccidial. Expired ES315612A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US383910A US3320124A (en) 1964-07-20 1964-07-20 Method for treating coccidiosis with quinazolinones

Publications (1)

Publication Number Publication Date
ES315612A1 true ES315612A1 (es) 1966-07-01

Family

ID=23515259

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0315612A Expired ES315612A1 (es) 1964-07-20 1965-07-20 Procedimiento para la preparacion de una composicion anticoccidial.

Country Status (7)

Country Link
US (1) US3320124A (enExample)
BR (1) BR6571429D0 (enExample)
DE (1) DE1545551B2 (enExample)
ES (1) ES315612A1 (enExample)
FR (1) FR1550956A (enExample)
GB (1) GB1087015A (enExample)
IL (1) IL23717A (enExample)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2339402A1 (fr) * 1976-01-29 1977-08-26 Roussel Uclaf Nouvelle quinazolinone et ses sels, leurs procede de preparation et leur application comme medicament
DE2934069A1 (de) * 1979-08-23 1981-03-12 Hoechst Ag, 6000 Frankfurt Mittel gegen theileriosen und seine verwendung.
FR2467630A1 (fr) * 1979-10-23 1981-04-30 Roussel Uclaf Nouvelles resines echangeuses d'ions du type acide, leur procede de preparation et leur application comme medicament
US4364928A (en) * 1979-10-23 1982-12-21 Roussel-Uclaf Novel salts of ion exchange resins of the acid type
US4797486A (en) * 1986-09-08 1989-01-10 Pfizer Inc. Heterocyclic ring fused pyrimidine-4(3H)-ones as anticoccidial agents
US4725599A (en) * 1986-09-08 1988-02-16 Pfizer Inc. Heterocyclic ring fused pyrimidine-4 (3H)-ones as anticoccidial agents
US5314700A (en) * 1991-01-28 1994-05-24 Ethyl Corporation Poultry feed component
CA2113229C (en) * 1994-01-11 1999-04-20 Mark Pines Anti-fibrotic quinazolinone-containing compositions and methods for the use thereof
IL110831A (en) * 1994-08-31 1998-12-27 Hadasit Med Res Service Pharmaceutical compositions containing quinazolinone derivatives for preventing restenosis
IL112125A (en) * 1994-12-22 1998-02-08 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions
IL114951A (en) * 1995-08-15 1999-08-17 Hadasit Med Res Service Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
US6090814A (en) * 1995-08-15 2000-07-18 Agricultural Research Organization Ministry Of Agriculture Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization
JP2001500040A (ja) * 1996-08-30 2001-01-09 イスラエル国 キナゾリノン誘導体を含有する冠状動脈内ステント
US6028075A (en) 1997-02-11 2000-02-22 Pines; Mark Quinazolinone containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies
JP2002515905A (ja) * 1997-05-23 2002-05-28 ハダシット・メディカル・リサーチ・サービセズ・アンド・ディベロップメント・カンパニー・リミテッド 肝硬変の治療
US6562829B1 (en) 1997-05-23 2003-05-13 Hadasit Medical Research Services & Development Co., Ltd. Treatment of hepatic cirrhosis
US6159488A (en) * 1997-08-14 2000-12-12 Agricultural Research Org. Ministry Of Agriculture (Gov.) Intracoronary stents containing quinazolinone derivatives
ATE307586T1 (de) * 1998-08-13 2005-11-15 Hadasit Med Res Service Hemmung von mit gewebetrauma verbundenen pathogenen prozessen
US7230000B1 (en) 1999-10-27 2007-06-12 Cytokinetics, Incorporated Methods and compositions utilizing quinazolinones
US6545004B1 (en) 1999-10-27 2003-04-08 Cytokinetics, Inc. Methods and compositions utilizing quinazolinones
IL143366A0 (en) * 2001-05-24 2002-04-21 Harasit Medical Res Services & Treatment of renal fibrosis
US6753428B2 (en) * 2001-11-20 2004-06-22 Cytokinetics, Inc. Process for the racemization of chiral quinazolinones
IL147416A (en) * 2001-12-31 2008-11-26 Israel State Combined modalities for improved cancer treatment
WO2003070701A2 (en) * 2002-02-15 2003-08-28 Cytokinetics, Inc. Syntheses of quinazolinones
IL148292A (en) * 2002-02-21 2008-08-07 Shai Yarkoni Stable preparations of lupoginone and other quinazolinone derivatives
WO2003094839A2 (en) * 2002-05-09 2003-11-20 Cytokinetics, Inc. Pyrimidinone compounds, compositions and methods
AU2003270015A1 (en) 2002-05-09 2003-12-02 Cytokinetics, Inc. Compounds, compositions, and methods
JP2005536475A (ja) * 2002-05-23 2005-12-02 サイトキネティクス・インコーポレーテッド 化合物、組成物、および方法
EP1556357A4 (en) * 2002-06-14 2006-09-13 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
EP1537089A4 (en) * 2002-07-23 2008-04-16 Cytokinetics Inc CONNECTIONS, COMPOSITIONS AND PROCEDURES
AU2003262747A1 (en) * 2002-08-21 2004-03-11 Cytokinetics, Inc. Compounds, compositions, and methods
EP1558083A4 (en) * 2002-09-30 2008-04-16 Cytokinetics Inc COMPOUNDS, COMPOSITIONS AND METHODS
WO2005041888A2 (en) * 2003-11-03 2005-05-12 Cytokinetics, Inc. Pyrimidin-4-one compounds, compositions and methods
US20050148593A1 (en) * 2003-11-07 2005-07-07 Gustave Bergnes Compounds, compositions, and methods
JP2007513154A (ja) * 2003-12-08 2007-05-24 サイトキネティクス・インコーポレーテッド 化合物、組成物及び方法
CN1304391C (zh) * 2004-02-06 2007-03-14 上海因诺生化科技有限公司 氢溴酸常山酮的制备方法
EP1855684A4 (en) * 2005-02-23 2011-04-06 Collgard Biopharmaceuticals Ltd PHARMACEUTICAL COMPOSITIONS OF THE ISOLATED D-ENANTIOMER OF THE CHINAZOLINONE DERIVATIVE HALOFUGINONE
WO2007120606A2 (en) * 2006-04-10 2007-10-25 President And Fellows Of Harvard College Methods for modulating formation and progression of cellulite
US8754107B2 (en) * 2006-11-17 2014-06-17 Abbvie Inc. Aminopyrrolidines as chemokine receptor antagonists
ES2447834T3 (es) 2007-01-21 2014-03-13 Agricultural Research Organization Composición y método para tratar o prevenir la fibrosis del músculo esquelético
US20110212100A1 (en) * 2007-08-15 2011-09-01 Tracy Keller Methods for modulating development and expansion of il-17 expressing cells
US20090123389A1 (en) * 2007-08-15 2009-05-14 Malcolm Whitman Methods for modulating Th17 cell development in the treatment and prevention of cellulite
FR2922451A1 (fr) * 2007-10-23 2009-04-24 Windgan Trading Traitement des retrecissements de l'uretre
EP2331525A4 (en) * 2008-08-11 2013-01-02 Harvard College HALOFUGINONE ANALOGUE FOR INHIBITING TRNA SYNTHETASES AND APPLICATIONS THEREOF
US8357692B2 (en) 2010-06-20 2013-01-22 Washington University Methods of treatment of bone degenerative diseases
EP2802572B1 (en) 2012-01-13 2018-11-07 President and Fellows of Harvard College Halofuginol derivatives and their use in cosmetic and pharmaceutical compositions
US11708353B2 (en) 2018-06-08 2023-07-25 The General Hospital Corporation Inhibitors of prolyl-tRNA-synthetase
CN111233831A (zh) * 2020-03-18 2020-06-05 郑州市华农兽药研究院 常山铜琥珀酸单酯及其制备方法与用途
CN112409272B (zh) * 2020-11-26 2025-09-16 河北美荷药业有限公司 一种6-氯-7-溴-4(3h)-喹唑啉酮的制备方法和应用

Also Published As

Publication number Publication date
DE1545551A1 (de) 1969-10-16
DE1545551B2 (de) 1976-12-23
BR6571429D0 (pt) 1973-08-14
FR1550956A (enExample) 1968-12-27
IL23717A (en) 1971-01-28
US3320124A (en) 1967-05-16
GB1087015A (en) 1967-10-11

Similar Documents

Publication Publication Date Title
ES315612A1 (es) Procedimiento para la preparacion de una composicion anticoccidial.
ES8201549A1 (es) Procedimiento para la obtencion de derivados de 3,4,5-trihi-droxipiperidina
SE306139B (enExample)
ES337254A1 (es) Procedimiento para la preparacion de composiciones para combatir las algas.
ES336244A1 (es) Procedimiento para preparar una composicion fitotoxica.
ES323287A1 (es) Procedimiento para preparar compuestos de pirrolindazol sustituido.
ES332921A1 (es) Procedimiento para la preparacion de un material poliester.
ES294501A1 (es) Un método para la preparación de un combustible o un lubricante
ES448389A1 (es) Procedimiento para la preparacion de isotiazolilureas susti-tuidas.
GB1110581A (en) Animal feed compositions
ES326765A1 (es) Procedimiento para la preparacion de un herbicida selectivo.
ES392848A1 (es) Un procedimiento para la preparacion de nuevos derivados de indenopirrol.
ES286969A1 (es) Un procedimiento para la preparación de una composición de pienso para animales
GB1366005A (en) Substuted cyanobenzimidazoles
ES292474A1 (es) Procedimiento para la preparación de una composición estabilizada de polímero hidrocarburo
ES322642A1 (es) Procedimiento para la preparacion de una mezcla herbicida.
GB974755A (en) Poultry foods
ES344111A1 (es) Un procedimiento para preparar una composicion util para incrementar el contenido de azucar de un cultivo de azucar.
ES302764A1 (es) Mejoras introducidas en la preparacion de composiciones de combustible.
JPS51135280A (en) Mineral additive for feed
GB1157379A (en) Method of Burning Coal and Coal Compositions
ES369889A1 (es) Procedimiento para la preparacion de quinoxalin-1,4-dioxi- dos.
GB1090707A (en) Mitomycin c derivatives
ES311702A1 (es) Procedimiento de producciën de composiciones para el estimulo del desarrollo de los vegetales
JPS5247993A (en) Method of preparing carcinostatic agent